EU notified bodies trained in Taiwanese regulations:
This article was originally published in Clinica
Executive Summary
As Clinica went to press, the European Commission unit responsible for medical devices was due to receive on April 7-8 a delegation from the Chinese Taipei which is visiting Brussels to train EU notified bodies in the Chinese Taipei medical device regulatory system. This is part of a trade agreement between the Chinese Taipei and the EU, which, although not an MRA, has been described as the nearest thing to one (see Clinica No 1149, p 3). An EU delegation is due to go to the Chinese Taipei either in November 2005 or November 2006.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.